Related Experiment Video
Updated: Sep 10, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
Mechanisms of the effect of gut microbes on depression through the microbiota-gut-brain axis
Xiangyan Zhou1,2, Sixing Wang1,3, Xiaohui Wang4
1Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Depression is a significant public health issue which exerts profound psychological and social impacts on both individuals and society. However, existing therapeutic strategies often exhibit limited efficacy. Accumulating evidence underscores the vital role of gut microbiota in the pathophysiology of depression through the microbiota-gut-brain (MGB) axis. This involves multiple mechanisms, including short-chain fatty acid (SCFA) metabolism, communication via the vagal nerve, regulation of the hypothalamic-pituitary-adrenal (HPA) axis, and immune-inflammatory interactions. This review provides a comprehensive review of the mechanisms through which gut microbiota influences depression via the MGB axis. It synthesizes recent achievements in this field and evaluates the potential of microbiome-targeted therapies for depression treatment. Furthermore, it outlines future research directions to establish a theoretical framework for novel therapeutic approaches and to foster the development of this area.
Insights
The gut microbiota influences depression through the microbiota-gut-brain axis via mechanisms like SCFA metabolism and immune interactions. Microbiome-targeted therapies show potential for treating depression.
Area of Science:
- Neuroscience
- Microbiology
- Psychiatry
Background:
- Depression is a major public health concern with significant individual and societal impacts.
- Current depression treatments have limited efficacy.
- Emerging evidence highlights the gut microbiota's role in depression via the microbiota-gut-brain (MGB) axis.
Purpose of the Study:
- To comprehensively review the mechanisms linking gut microbiota to depression through the MGB axis.
- To synthesize recent research findings in this field.
- To evaluate the therapeutic potential of microbiome-targeted interventions for depression.
Main Methods:
- Literature review synthesizing current research on the MGB axis and depression.
- Analysis of mechanisms including short-chain fatty acid (SCFA) metabolism, vagal nerve communication, HPA axis regulation, and immune-inflammatory pathways.
- Evaluation of emerging microbiome-targeted therapies.
Main Results:
- The gut microbiota influences depression through multiple pathways within the MGB axis.
- Key mechanisms include SCFA production, neural signaling via the vagal nerve, HPA axis modulation, and immune system regulation.
- Microbiome-based interventions are a promising area for novel depression treatments.
Conclusions:
- The gut microbiota plays a crucial role in depression pathophysiology via the MGB axis.
- Understanding these mechanisms is key to developing effective microbiome-targeted therapies.
- Further research is needed to establish a theoretical framework for novel therapeutic approaches.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
G-protein Coupled Receptors
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Hormonal Regulation

